Unknown

Dataset Information

0

Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.


ABSTRACT:

SUBMITTER: Hemmingsen B 

PROVIDER: S-EPMC6481586 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.

Hemmingsen Bianca B   Sonne David P DP   Metzendorf Maria-Inti MI   Richter Bernd B  

The Cochrane database of systematic reviews 20170510


<h4>Background</h4>The projected rise in the incidence of type 2 diabetes mellitus (T2DM) could develop into a substantial health problem worldwide. Whether dipeptidyl-peptidase (DPP)-4 inhibitors or glucagon-like peptide (GLP)-1 analogues are able to prevent or delay T2DM and its associated complications in people at risk for the development of T2DM is unknown.<h4>Objectives</h4>To assess the effects of DPP-4 inhibitors and GLP-1 analogues on the prevention or delay of T2DM and its associated c  ...[more]

Similar Datasets

| S-EPMC3898344 | biostudies-literature
| S-EPMC10980663 | biostudies-literature
| S-EPMC6486297 | biostudies-literature
| S-EPMC9973397 | biostudies-literature
| S-EPMC10712048 | biostudies-literature
| S-EPMC9597445 | biostudies-literature
| S-EPMC8390252 | biostudies-literature
| S-EPMC4985332 | biostudies-literature
| S-EPMC3948731 | biostudies-literature
| S-EPMC3017518 | biostudies-literature